VentureBeat

I’ll be posting my reports from last week’s JPMorgan Healthcare Conference over the next day or two. Since few of them involve actual news — this particular conference is big on schmoozing and relatively short on major announcements, especially where venture-stage firms are concerned — I’ve been getting some other backlogged posts out of the way first. (The conference itself, which for me was mostly wall-to-wall meetings and after-hour receptions, was far too hectic for me to put together anything resembling a coherent report.) Don’t fret, though, as notebook dumps are on their way.

It’s a new year, and legions of dark-suited analysts, investors and biotech/medical device executives are once again creating a fire hazard in the cramped confines of the Westin St. Francis Hotel in San Francisco. It’s the signature biotech meeting of the year, the JPMorgan Healthcare Conference, an annual meet market for healthcare companies of all stripes to hawk their good news, buttonhole investors, and otherwise spread optimism about their prospects far and wide.

I’ll be blogging from the conference for the next few days, so other posting may be somewhat more sporadic. My hopes of posting daily have already fallen victim to the frenetic schedule here, but watch for updates.